Non-bacterial thrombotic endocarditis: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Non-bacterial thrombotic endocarditis}} | {{Non-bacterial thrombotic endocarditis}} | ||
{{CMG}}; {{AE}}{{ | {{CMG}}; {{AE}}{{Aisha}} | ||
{{SK}}[[marantic endocarditis]], [[nonbacterial thrombotic endocarditis]], [[NBTE]], [[non-infective endocarditis]], [[noninfective endocarditis]], [[noninfective thrombotic endocarditis]], [[non-infective thrombotic endocarditis]] | {{SK}}[[marantic endocarditis]], [[nonbacterial thrombotic endocarditis]], [[NBTE]], [[non-infective endocarditis]], [[noninfective endocarditis]], [[noninfective thrombotic endocarditis]], [[non-infective thrombotic endocarditis]] |
Revision as of 13:07, 10 July 2020
non-bacterial thrombotic endocarditis |
Differentiating non-bacterial thrombotic endocarditis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Non-bacterial thrombotic endocarditis On the Web |
American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis |
Risk calculators and risk factors for Non-bacterial thrombotic endocarditis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Synonyms and keywords:marantic endocarditis, nonbacterial thrombotic endocarditis, NBTE, non-infective endocarditis, noninfective endocarditis, noninfective thrombotic endocarditis, non-infective thrombotic endocarditis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Non-bacterial thrombotic endocarditis from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Endomyocardial Biopsy | Chest X Ray | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies